Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
3(13%)
Results Posted
11%(1 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_3
5
22%
Ph not_applicable
3
13%
Ph phase_2
2
9%
Ph phase_4
13
57%

Phase Distribution

0

Early Stage

2

Mid Stage

18

Late Stage

Phase Distribution23 total trials
Phase 2Efficacy & side effects
2(8.7%)
Phase 3Large-scale testing
5(21.7%)
Phase 4Post-market surveillance
13(56.5%)
N/ANon-phased studies
3(13.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

3

trials recruiting

Total Trials

23

all time

Status Distribution
Active(5)
Completed(9)
Terminated(2)
Other(7)

Detailed Status

Completed9
unknown7
Recruiting3
Terminated2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
23
Active
3
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (8.7%)
Phase 35 (21.7%)
Phase 413 (56.5%)
N/A3 (13.0%)

Trials by Status

completed939%
recruiting313%
unknown730%
terminated29%
not_yet_recruiting29%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT05793996Phase 4

The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)

Recruiting
NCT04915820Not Applicable

Iron and COVID-19 Vaccine Response

Completed
NCT05759078Phase 4

Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion

Recruiting
NCT05226169Phase 3

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Recruiting
NCT06061393Phase 4

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

Unknown
NCT05708170Phase 4

Impact of Intravenous Iron on Musculoskeletal Function in Older Adults

Not Yet Recruiting
NCT01975272Phase 4

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

Terminated
NCT03388385Phase 4

Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD

Unknown
NCT05429749Phase 4

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Unknown
NCT04862715Phase 4

The Iron and Muscle Study

Completed
NCT05114278Phase 4

Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)

Not Yet Recruiting
NCT04912661Not Applicable

Iron and Vaccine Response

Completed
NCT04898569Phase 4

Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting

Unknown
NCT02469480Phase 2

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Completed
NCT04187716Phase 3

Intravenous Iron Injection in Cancer Patients With Anemia

Unknown
NCT03625661Not Applicable

Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With Cancer

Completed
NCT02599012Phase 2

The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients

Unknown
NCT01725789Phase 3

Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)

Completed
NCT02939794Phase 4

The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery

Unknown
NCT01131624Phase 3

Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23